{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:14:26Z","timestamp":1777392866640,"version":"3.51.4"},"reference-count":38,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Transplantation"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Renal graft thrombosis (RGT) is one of the main causes for early graft loss in pediatric kidney transplantation (KTx). Despite the lack of evidence\u2010based recommendations, antithrombotic prophylaxis (aP) is used to prevent RGT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An online survey supported by the European Society for Pediatric Nephrology was developed to investigate the current practice of aP in pediatric KTx recipients &lt;18\u00a0years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 80 pediatric KTx centers from 37 countries participated in the survey. Antithrombotic prophylaxis was performed in 96% of the pediatric renal transplant centers (all\/selected patients: 54%\/42%). The main overall used drugs were as follows: low\u2010molecular\u2010weight heparin (89%), unfractionated heparin (UFH) (69%), and acetylsalicylic acid (ASS) (55%). Ten different aP management strategies were identified as follows: 51% used a single drug and 48% combined two drugs sequentially. The corresponding centers started aP predominantly within 24\u00a0hours after pediatric KTx; 51% preferred UFH for starting aP. In centers switching to a second drug (51%), this change was performed after 10\u00a0\u00b1\u00a06\u00a0days; of these 57% preferred ASS for maintenance aP. Reported median aP duration was 51\u00a0days (range 1\u2010360).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Despite the use of aP in almost all responding pediatric KTx centers, there is no uniform management strategy. Notwithstanding, UFH seems to be the preferred drug for the early post\u2010operative period of pediatric KTx, and ASS for maintenance prophylaxis following pediatric KTx. Prospective studies are needed to further evaluate the benefits and risks of aP, preferably resulting in guidelines for the management in pediatric KTx.<\/jats:p><\/jats:sec>","DOI":"10.1111\/petr.13799","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T03:50:55Z","timestamp":1598586655000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Current practice of antithrombotic prophylaxis in pediatric kidney transplantation\u2014Results of an international survey on behalf of the European Society for Paediatric Nephrology"],"prefix":"10.1111","volume":"24","author":[{"given":"Kathrin","family":"Buder","sequence":"first","affiliation":[{"name":"Pediatric Nephrology Department University Children`s Hospital Zurich Zurich Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Zirngibl","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics and Hematology\/Oncology University Hospital T\u00fcbingen University Children`s Hospital T\u00fcbingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sascha","family":"Bapistella","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics and Hematology\/Oncology University Hospital T\u00fcbingen University Children`s Hospital T\u00fcbingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Nadalin","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplant Surgery University Hospital T\u00fcbingen T\u00fcbingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6598-6910","authenticated-orcid":false,"given":"Burkhard","family":"T\u00f6nshoff","sequence":"additional","affiliation":[{"name":"Department of Pediatrics I University Children's Hospital Heidelberg Heidelberg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1696-5646","authenticated-orcid":false,"given":"Marcus","family":"Weitz","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics and Hematology\/Oncology University Hospital T\u00fcbingen University Children`s Hospital T\u00fcbingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Members of the \u201cTransplantation Working Group\u201d of the European Society for Paediatric Nephrology (ESPN)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,8,18]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1314376"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13597"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01213.x"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2018.01.027"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2001.01671.x"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1603364"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2009.01260.x"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199705150-00012"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13006"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13512"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-004-1458-4"},{"issue":"1","key":"e_1_2_11_13_1","first-page":"1384","article-title":"Preventive treatment of vascular thrombosis after kidney transplantation in children with low molecular weight heparin","volume":"23","author":"Broyer M","year":"1991","journal-title":"Transplant Proc"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.6002\/ect.2018.0358"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2006.12.017"},{"issue":"2","key":"e_1_2_11_16_1","first-page":"141","article-title":"Protective effect of heparin and aspirin against vascular thrombosis in pediatric kidney transplants","volume":"6","author":"Esfandiar N","year":"2012","journal-title":"Iran J Kidney Dis"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2009.07.106"},{"key":"e_1_2_11_18_1","doi-asserted-by":"crossref","DOI":"10.1002\/9781394260645","volume-title":"Internet, phone, mail, and mixed\u2010mode surveys: the tailored design method","author":"Dillman DA","year":"2014"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.11.1865"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-3895-5"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-199909010-00012"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/tri.13387"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.5414\/CNP74351"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2018.07.041"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D510"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2308"},{"key":"e_1_2_11_27_1","volume-title":"Acetylsalicylic Acid for Venous Thromboembolism Prophylaxis: Comparative Clinical Effectiveness and Guidelines","author":"Poitras V","year":"2017"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.15101"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2005.00483.x"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1289"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1597298"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2295"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.22.3.184.33541"},{"issue":"3","key":"e_1_2_11_34_1","first-page":"253","article-title":"Activated partial thromboplastin time monitoring of unfractionated heparin therapy: issues and recommendations","volume":"43","author":"Marlar RA","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13314"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-008-9278-4"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.06.044"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13385"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv392"}],"container-title":["Pediatric Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/petr.13799","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/petr.13799","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/petr.13799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T18:40:26Z","timestamp":1723488026000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/petr.13799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1111\/petr.13799"],"URL":"https:\/\/doi.org\/10.1111\/petr.13799","archive":["Portico"],"relation":{},"ISSN":["1397-3142","1399-3046"],"issn-type":[{"value":"1397-3142","type":"print"},{"value":"1399-3046","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,18]]},"assertion":[{"value":"2020-04-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e13799"}}